28/ May 2020 (Thursday) - Transfusion News Update

The Transfusion News talks about the use of convalescent plasma for the treatment of patients with COVID-19… We’ve started stocking the stuff.
Perhaps COVID-19 *is* more relevant to me than I thought?

Convalescent Plasma Decreases Mortality for Non-Intubated Patients with Severe COVID-19
May 27, 2020
Based on a preliminary propensity score-matched control study, convalescent plasma is beneficial for non-intubated patients with severe COVID-19. At the Mount Sinai Hospital in New York City, 39 hospitalized patients (average age, 55 years; 64% male) with severe to life-threatening COVID-19 were transfused with [Read More]
Convalescent Plasma for COVID-19 Safe in First 5,000 Patients
May 19, 2020
With limited therapies for patients with COVID-19 and a mortality rate of approximately 50% for patients in the ICU, demand is high for convalescent plasma from individuals who have recovered from COVID-19. Convalescent plasma has been requested for [Read More]

No comments:

Post a Comment